Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity

Microbes and Infection

Volumn 6, Issue 12, 2004, Pages 1049-1055

  Maher, Caroline F ^a   Hussell, Tracy ^a   Blair, Edward ^b   Ring, Christopher J A ^b   Openshaw, Peter J M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; Bronchiolitis, viral; Common cold; Immunity, mucosal; Pneumovirinae

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; THROMBOSPONDIN; VIRUS PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ATTENUATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LARYNX TUMOR; LUNG INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENSITIZATION; TUMOR CELL; VACCINIA; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CELL LINE; CHEMOKINE CCL2; CRICETINAE; HUMANS; IMMUNITY, MUCOSAL; LUNG; MICE; MICE, INBRED BALB C; RECOMBINATION, GENETIC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL PROTEINS; VIRUS REPLICATION;

PNEUMOVIRINAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 4544329925     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.07.001     Document Type: Article

References (33)

1. Hall C.B. Respiratory syncytial virus and parainfluenza virus New Engl. J. Med. 344 2001 1917 1928
2. McIntosh K., and Fishaut J.M. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus Prog. Med. Virol. 26 1980 94 118
3. Sparer T.E., Matthews S., Hussell T., Rae A.J., García-Barreno B., Melero J.A., and Openshaw P.J.M. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia J. Exp. Med. 187 1998 1921 1926
4. Bukreyev A., Skiadopoulos M.H., McAuliffe J., Murphy B.R., Collins P.L., and Schmidt A.C. More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved? Proc. Natl. Acad. Sci. USA 99 2002 16987 16991
5. Openshaw P.J.M., Culley F.J., and Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease Vaccine 20 2001 s27 s31
6. Bembridge G.P., Lopez J.A., Bustos R., Melero J.A., Cook R., Mason H., and Taylor G. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge J. Virol. 73 1999 10086 10094
7. Johnson T.R., and Graham B.S. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism J. Virol. 75 1999 8485 8495
8. Johnson T.R., Johnson J.E., Roberts S.R., Wertz G.W., Parker R.A., and Graham B.S. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge J. Virol. 72 1998 2871 2880
9. Teng M.N., Whitehead S.S., and Collins P.L. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo Virology 289 2001 283 296
10. Collins P.L., Hill M.G., Camargo E., Grosfeld H., Chanock R.M., and Murphy B.R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development Proc. Natl. Acad. Sci. USA 92 1995 11563 11567
11. Hussell T., Khan U., and Openshaw P.J.M. IL-12 treatment attenuates Th2 and B cell responses but does not improve vaccine-enhanced lung illness J. Immunol. 159 1997 328 334
12. Hallensleben W., Biro L., Sauder C., Hausmann J., Asensio V.C., Campbell I.L., and Staeheli P. A polymorphism in the mouse crg-2/IP-10 gene complicates chemokine gene expression analysis using a commercial ribonuclease protection assay J. Immunol. Methods 234 2000 149 151
13. Haeberle H.A., Kuziel W.A., Dieterich H.J., Casola A., Gatalica Z., and Garofalo R.P. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology J. Virol. 75 2001 878 890
14. Tripp R.A., Jones L., and Anderson L.J. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse J. Virol. 74 2000 6227 6229
15. Coates H.V., Alling D.W., and Chanock R.M. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test Am. J. Epidemiol. 83 1966 299 313
16. Jin H., Clarke D., Zhou H.Z., Cheng X., Coelingh K., Bryant M., and Li S. Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV Virology 251 1998 206 214
17. Elliott M.B., Pryharski K.S., Yu Q., Parks C.L., Laughlin T.S., Gupta C.K., Lerch R.A., Randolph V.B., LaPierre N.A., Dack K.M., and Hancock G.E. Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro J. Virol. 78 2004 5773 5783
18. Openshaw P.J.M., Clarke S.L., and Record F.M. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G Int. Immunol. 4 1992 493 500
19. Alwan W.H., Kozlowska W.J., and Openshaw P.J.M. Distinct types of lung disease caused by functional subsets of antiviral T cells J. Exp. Med. 179 1994 81 89
20. Schwarze J., and Schauer U. Enhanced virulence, airway inflammation and impaired lung function induced by respiratory syncytial virus deficient in secreted G protein Thorax 59 2004 517 521
21. Wertz G.W., Krieger M., and Ball L.A. Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation J. Virol. 63 1989 4767 4776
22. Hussell T., and Openshaw P.J.M. IL-12 activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness after lung challenge in CD8 cell-immunodeficient conditions J. Immunol. 165 2000 7109 7115
23. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus Infection J. Exp. Med. 186 1997 421 432
24. Langedijk J.P., de Groot B.L., Berendsen H.J., and Van Oirschot J.T. Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor Virology 243 1998 293 302
25. Tripp R.A., Jones L.P., Haynes L.M., Zheng H., Murphy P.M., and Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein Nat. Immun. 2 2001 732 738
26. Hussell T., Pennycook A., and Openshaw P.J.M. Inhibition of tumour necrosis factor reduces the severity of virus-specific lung immunopathology Eur. J. Immunol. 31 2001 2566 2573
27. Walzl G., Matthews S., Kendall S., Gutiérrez-Ramos J.C., Coyle A.J., Openshaw P.J.M., and Hussell T. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents Th2- but not Th1-driven immunopathology J. Exp. Med. 193 2001 785 792
28. + T-cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection Eur. J. Immunol. 27 1997 3341 3349
29. Zhang Y., Luxon B.A., Casola A., Garofalo R.P., Jamaluddin M., and Brasier A.R. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays J. Virol. 75 2001 9044 9058
30. Tripp R.A., Moore D., Barskey A., Jones L., Moscatiello C., Keyserling H., and Anderson L.J. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA J. Infect. Dis. 185 2002 1388 1394
31. Chung H.L., and Kim S.G. RANTES may be predictive of later recurrent wheezing after respiratory syncytial virus bronchiolitis in infants Ann. Allergy Asthma Immunol. 88 2002 463 467
32. Gern J.E., and Busse W.W. Relationship of viral infections to wheezing illnesses and asthma Nat. Rev. Immunol. 2 2002 132 138
33. Tekkanat K.K., Maassab H., Miller A., Berlin A.A., Kunkel S.L., and Lukacs N.W. RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease Eur. J. Immunol. 32 2002 3276 3284